L
Lysogene
Paris, France
Founded 2009 Euronext: LYS
About
CNS-targeted gene therapy for lysosomal storage diseases
Company Details
- Type
- public
- Employees
- 50+
- Funding
- Public
Key Products
- LYS-GM101
- CNS Gene Therapy
CNS-targeted gene therapy for lysosomal storage diseases